pharmaphorum

DECEMBER 1, 2022

To ease this burden, the life sciences industry has been searching for ways to make clinical trials more accessible for patients and to drive participation numbers, increase participant diversity, and improve overall patient experience. Imagine, clinical research as an accessible care option to anyone.

Clinical Trials 111

Clinical Trials Clinical Trials Trials Clinical Research 111

Velocity Clinical Research

OCTOBER 21, 2024

At the beginning of September, Velocity Clinical Research topped Business North Carolina ’s 2024 Fast 40 list. For a clinical trials organization to achieve this level of scale is notable. This is vital if we’re to ensure that drug trials are inclusive and deliver results that are representative of the entire population.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

XTalks

JULY 29, 2021

Just as clinical researchers in other therapeutic areas have renewed their commitment to improving participant diversity in clinical trials, so too have those working in Alzheimer’s research. What Factors Promote Alzheimer’s Clinical Trial Participation?

Clinical Trials 98

Clinical Trials Clinical Trials Trials Research 98

XTalks

AUGUST 4, 2022

This started back in 1993 when the FDA established guidelines to increase diversity by gender and race/ethnicity of participants in clinical trials that were contributing to new drug approvals. Why Should We Care About Diversity and Equity in Clinical Research? In the same webinar, Dr. Hansie M.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

XTalks

SEPTEMBER 13, 2024

The Clinical Trials Transformation Initiative (CTTI) aims to change this narrative by developing recommendations and driving the adoption of practices that support inclusivity and representativeness of all patient populations in clinical research.

Trials 52

Trials Clinical Trials Clinical Trials Clinical Research 52